Effects of preemptive Ketamine on post-cesarean analgesic requirement

Abstract:
Abstract: In a randomized, double blind study, we compared post operative pain and analgesic requirement in patients undergoing cesarean section with two types of general anesthesia: standardized general anesthesia (control group=26 cases) and preemptive low-dose ketamine (0.2 mg/kg) administered prior to anesthesia induction (keratmine group=27 cases). Postoperative analgesia was provided for both groups using morphine intravenously based on visual analogue scale (VAS). After the operation we found that the time from the end of surgery to the first request for analgesic was longer in ketamine group (10.22±8 hrs) than in the control group (1.65±1.01 hrs0 (P<0.001) Mean dose of morphine consumption over 24 hrs was less in the ketamine group (625±3.45 mg) than in the control group (17.73±4.08 mg) (P<0.001) VAS of pain scores were lower in ketamine group during 24 hr (P<0.001). APGAR Scores were similar between the groups. No patient in either group had postoperative hallucination. In conclusion, ketamine in low dose has a preemptive analgesia effect that reduces central sensitization in cesarean section and reduces postoperative analgesic requirement.
Language:
English
Published:
Page:
100
magiran.com/p518440  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!